Table 3 Relation between mortality and different clinical parameters

 Absent

713 (96.7%)

32 (94.1%)

^MCp = 0.180

 Present

24 (3.2%)

2 (5.8%)

Neuropathy

49 (6.6%)

4 (11.8%)

^FEp= 0.284

Transverse myelitis

2 (0.3%)

0 (0%)

^FEp= 1.000

GFR

10 (1.4%)

4 (11.8%)

^FEp= 0.002^*

 Absent

724 (98.2%)

24 (70.6%)

^FEp <0.001^*

 Present

13 (1.8%)

10 (29.4%)

Pulmonary hypertension

32 (4.3%)

3 (8.8%)

^FEp = 0.196

Pulmonary fibrosis

27 (3.7%)

2 (5.9%)

^FEp = 0.370

Pulmonary fibrosis

10 (1.4%)

2 (5.9%)

^FEp = 0.094

Pulmonary infarction

5 (0.7%)

2 (5.9%)

^FEp = 0.035^*

Shrink lung

14 (1.9%)

3 (8.8%)

^FEp = 0.035^*

Angina

15 (2%)

0 (0%)

^FEp = 1.000

Myocardial infarction

2 (0.3%)

0 (0%)

^FEp = 1.000

Cardio-myopathy

35 (4.7%)

7 (20.6%)

^FEp = 0.002^*

Valvular

80 (10.9%)

6 (17.6%)

^FEp = 0.257

Pericarditis

71 (9.6%)

2 (5.9%)

^FEp = 0.763

Venous thrombosis

82 (11.1%)

4 (11.8%)

^FEp = 0.785

Bowel infarction

31 (4.2%)

1 (2.9%)

^FEp = 1.000

 No

686 (93.1%)

30 (88.2%)

^MCp = 0.053

 Unilateral

26 (3.5%)

0 (0%)

 Bilateral

25 (3.4%)

4 (11.8%)

OP with fracture

36 (4.9%)

5 (14.7%)

^FEp = 0.029^*

Osteomyelitis

0 (0%)

0 (0%)

–

Premature gonadal Failure

3 (0.4%)

0 (0%)

^FEp = 1.000

Diabetes

55 (7.5%)

4 (11.8%)

^FEp = 0.321

Malignancy

0 (0%)

1 (2.9%)

^FEp = 0.044^*

Infection

311 (42.2%)

27 (79.4%)

< 0.001^*

 Mean ± SD.

8.8 ± 8.3

9.8 ± 6.3

0.024^*

 Median (min.–max.)

6 (0–43)

8 (0–26)

APL +ve

208 (28.2%)

9 (26.5%)

0.824

 Mean ± SD.

1.5 ± 1.6

3.1 ± 2.6

< 0.001^*

 Median (min.–max.)

1 (0–8)

3 (0–11)